AlgometRx Awarded Two Small Business Innovation Research Grants from the NIH
In September of 2022, AlgometRx was awarded two Phase 1 SBIR awards from the National Cancer Institute (NCI) and the National Institute...
The AlgometRx Nociometer® enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Our novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of analgesics. This transformative platform technology can be applied to any population.